Senti Biosciences
SNTI
SNTI
39 hedge funds and large institutions have $209M invested in Senti Biosciences in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Holders
39
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.39M | |
| 2 | +$2.36M | |
| 3 | +$1.37M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$930K |
| 5 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$208K |
Top Sellers
| 1 | -$1.79M | |
| 2 | -$1.15M | |
| 3 | -$923K | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$875K |
| 5 |
JGC
J. Goldman & Co
New York
|
-$497K |